| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.9 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |